| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |